Cargando…

Reply: Changes in BMI after treatment of testicular cancer are due to age and hormonal function and not chemotherapy

Detalles Bibliográficos
Autores principales:	Nord, C, Fosså, S D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376969/ http://dx.doi.org/10.1038/sj.bjc.6601179

Ejemplares similares

Changes in BMI after treatment of testicular cancer are due to age and hormonal function and not chemotherapy
por: Huddart, R A, et al.
Publicado: (2003)

Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer
por: Nord, C, et al.
Publicado: (2003)

Reply: Comment on ‘Chemotherapy for testicular cancer induces acute alterations in diastolic heart function'
por: van Schinkel, L D, et al.
Publicado: (2014)

Reply to Stohner: On the significance of BMI-age dependence of exhaled aerosol
por: Edwards, David A., et al.
Publicado: (2021)

In Reply: Hormones and COVID-19
por: Park, Myung S., et al.
Publicado: (2023)

Testicular abscesses due to Brucella melitensis
por: Vallianou, N.G., et al.
Publicado: (2018)

Reply: The utilization of accurate body mass index classification is imperative for grouping based on BMI
por: Hernáez, Álvaro, et al.
Publicado: (2021)

Comment on ‘Chemotherapy for testicular cancer induces acute alterations in diastolic heart function'
por: Dieckmann, K-P
Publicado: (2014)

Authors’ Reply to: To Screen or Not to Screen? At Which BMI Cut Point? Comment on “Obesity and BMI Cut Points for Associated Comorbidities: Electronic Health Record Study”
por: Funk, Luke, et al.
Publicado: (2022)

Reply: ‘Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
por: Willemse, P M, et al.
Publicado: (2013)

Chemotherapy and quality of life in advanced NSCLC – reply
por: Anderson, Heather, et al.
Publicado: (2001)

Reply to ‘Malignant pericardial effusion: sclerotherapy or local chemotherapy?’
por: Kunitoh, H, et al.
Publicado: (2009)

Serum lactate dehydrogenase isoenzyme 1 as a prognostic predictor for metastatic testicular germ cell tumours – reply
por: Shamash, J
Publicado: (2000)

Low-fat high-carbohydrate diet and plasma sex hormones - reply
por: Boyd, N
Publicado: (1998)

Microalbuminuria and BMI
por: Wiwanitkit, V.
Publicado: (2009)

Reply: Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Aparicio, T, et al.
Publicado: (2004)

Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
por: Khan, O A, et al.
Publicado: (2012)

Reply: Internet chemotherapy information is of good quality: assessment with the DISCERN tool
por: Davies, E, et al.
Publicado: (2012)

Reply on “Successful Conservative Management of Hepatic Portal Venous Gas due to Anastomosis Leakage After a Sigmoidectomy”
por: Hong, Seongwoo
Publicado: (2020)

Associations of preorchiectomy hormone levels to testicular germ cell tumor pathology, clinical stage, and size
por: Pineault, Kevin G, et al.
Publicado: (2020)

Microdissection testicular extraction for a patient with transverse testicular ectopia and testicular fusion
por: Chen, Chen, et al.
Publicado: (2018)

The authors reply: Predictive role of hematologic parameters in testicular torsion
por: Güneş, Mustafa, et al.
Publicado: (2015)

Reply to Comment on “Osteoporosis in the Age of COVID-19”
por: Girgis, C. M., et al.
Publicado: (2021)

Maternal pregnancy hormone profiles in areas with a different incidence of breast cancer – reply
por: Lipworth1, L, et al.
Publicado: (2000)

In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program
por: Hao, Zhonglin, et al.
Publicado: (2023)

Fertility preservation after bilateral severe testicular trauma
por: Liguori, Giovanni, et al.
Publicado: (2014)

Reply: Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
por: Kollmannsberger, C, et al.
Publicado: (2003)

Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”
por: Hiraide, Sakura, et al.
Publicado: (2021)

Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy
por: Chen, Wei-Chun, et al.
Publicado: (2022)

Reply: Early-onset Behr syndrome due to compound heterozygous mutations in OPA1
por: Yu-Wai-Man, Patrick, et al.
Publicado: (2014)

Comment on ‘Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
por: Singhera, M, et al.
Publicado: (2013)

Reply: Spastic paraplegia in ‘dominant optic atrophy plus’ phenotype due to OPA1 mutation
por: Yu-Wai-Man, Patrick, et al.
Publicado: (2011)

RE: The value of testicular ultrasound in the prediction of the type and size of testicular tumors
por: Shtricker, Abraham, et al.
Publicado: (2016)

Reply to: Endothelium-dependent and -independent functions in migraineurs
por: Fujioka, Kazumi
Publicado: (2018)

Change in sex hormone profile due to exposure to nuclides in nuclear detonation crisis: a topic to be discussed in reproductive medicine
por: Wiwanitkit, Viroj
Publicado: (2012)

Reply: Implications of presymptomatic change in thalamus and caudate in Alzheimer’s disease
por: Ryan, Natalie S., et al.
Publicado: (2013)

IN REPLY
por: Goswami, Utpal
Publicado: (2003)

Reply
por: Thoresen, S.
Publicado: (1983)

Reply
por: Forrer, F., et al.
Publicado: (2007)

REPLY
por: Rao, A. Venkoba
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_pd001a090jcfdlvsfv1ih4er7g